Pieris Pharmaceuticals, Inc. (PIRS) SEC filings
PIRS SEC filings moved a median of -0.66% by the close. PIRS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the PIRS overview →
27 measured PIRS SEC filing events.
Where these PIRS SEC filings landedvs 26 measured PIRS SEC filing reactions
| Middle 50% of PIRS SEC filing reactions | -1.74% to +0.80% |
|---|---|
| Median reaction (to close) | -0.66% |
| Measured reactions | 26 |
Point-in-time · zero look-ahead
Half of the 26 PIRS SEC filing events with a measured close landed between -1.74% and +0.80%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K PALVELLA THERAPEUTICS, For: Dec 13 | SEC filing · Form 8-K | — | — | |
| Form SEC STAFF LETTER PIERIS PHARMACEUTICALS, | SEC filing · Form SEC | — | -4.76% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Dec 11 | SEC filing · Form 8-K | +1.59% | -9.99% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Dec 02 | SEC filing · Form 8-K | — | -5.24% | |
| Form 10-Q PIERIS PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | — | -0.37% | |
| Form EFFECT PIERIS PHARMACEUTICALS, | SEC filing · Form EFFECT | — | +1.51% | |
| Form S-4/A PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | — | -0.66% | |
| Form ARS PIERIS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form ARS | — | -0.66% | |
| Form DEF 14A PIERIS PHARMACEUTICALS, For: Dec 02 | SEC filing · Form DEF | — | -0.66% | |
| Form S-4/A PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | +2.21% | -1.79% | |
| Form S-4/A PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | — | -0.29% | |
| Form S-4/A PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | +0.68% | +0.87% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Oct 03 | SEC filing · Form 8-K | — | -1.57% | |
| Form S-4/A PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | -1.05% | +0.12% | |
| Form 10-Q PIERIS PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.81% | |
| Form S-4 PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | +0.00% | +4.82% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Aug 07 | SEC filing · Form 8-K | +0.00% | -2.70% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Jul 23 | SEC filing · Form 8-K | +17.53% | +14.71% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Jun 28 | SEC filing · Form 8-K | +6.44% | +4.09% | |
| Form 10-Q PIERIS PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.17% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: May 07 | SEC filing · Form 8-K | +0.00% | -1.41% | |
| Form 10-K/A PIERIS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.60% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Apr 18 | SEC filing · Form 8-K | -3.25% | -5.84% | |
| Form 10-K PIERIS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -0.05% | -1.58% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Mar 27 | SEC filing · Form 8-K | +0.58% | +1.95% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Dec 15 | SEC filing · Form 8-K | -4.38% | -1.50% | |
| Form 10-Q PIERIS PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | +0.17% | +0.61% |
Keep exploring
More PIRS: earnings → · analyst actions → · PIRS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ORGANIGRAM HOLDINGS INC (OGRMF) | 97 | +0.25% | 56% |
| Utah Medical Products, Inc. (UTMD) | 96 | 0.00% | 48% |
| ASTELLAS PHARMA UNSP/ADR (ALPMY) | 94 | +0.02% | 50% |
| Check-Cap Ltd. - Ordinary Share (CHEK) | 94 | -0.11% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.